R
Rohan Samson
Researcher at Tulane University
Publications - 38
Citations - 435
Rohan Samson is an academic researcher from Tulane University. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 8, co-authored 32 publications receiving 263 citations. Previous affiliations of Rohan Samson include University Medical Center New Orleans.
Papers
More filters
Journal ArticleDOI
Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
TL;DR: The syndrome of heart failure with preserved ejection fraction (HFpEF) received a lot of attention, but little therapeutic progress was made.
Journal ArticleDOI
Vascular and Microvascular Endothelial Function in Heart Failure With Preserved Ejection Fraction
Sylvestre Maréchaux,Rohan Samson,Eric Van Belle,Joke Breyne,Juliette de Monte,Céline Dédrie,Nassim Chebai,Aymeric Menet,Carlo Banfi,Nadia Bouabdallaoui,Thierry H. Le Jemtel,Pierre-Vladimir Ennezat,Pierre-Vladimir Ennezat +12 more
TL;DR: Compared with hypertensive control subjects, patients with HFpEF had a depressed endothelial function in the forearm vasculature and microvasculature.
Journal ArticleDOI
Epicardial Adipose Tissue and Cardiovascular Disease.
TL;DR: The association of epicardial adipose tissue with atrial fibrillation is robust, and the association of coronary artery disease and heart failure with preserved ejection fraction is tenuous.
Journal ArticleDOI
Visceral Adipose Tissue Accumulation and Residual Cardiovascular Risk.
TL;DR: Control of low-grade systemic inflammation requires reversal of visceral adipose tissue accumulation with intense and sustained aerobic exercise or bariatric surgery, and pharmacologic inhibition of the inflammatory signaling pathway may be considered.
Journal ArticleDOI
Instantaneous wave-free ratio as an alternative to fractional flow reserve in assessment of moderate coronary stenoses: A meta-analysis of diagnostic accuracy studies.
Rohit Maini,John C. Moscona,Paul Katigbak,Camilo Fernandez,Gursukhmandeep Sidhu,Qusai Saleh,Anand Irimpen,Rohan Samson,Thierry H. LeJemtel +8 more
TL;DR: iFR showed excellent agreement with FFR as a resting index of coronary stenosis severity without the undesired effects and cost of hyperemic agents, which supports its use as a suitable alternative to FFR for physiology-guided revascularization of moderate coronary stenoses.